Articles tagged with Cancer Treatments
A study of 797 breast cancer survivors found that only 33% received a mammogram each year over the five years after treatment. Regular mammography for breast cancer survivors declines steadily within five years of treatment, highlighting the need to increase awareness among healthcare providers and patients.
A national survey of 954 adults found that 44.7% of African-Americans and 33.5% of whites reported low trust in healthcare providers. Understanding these differences can help physicians improve trust and medical care for diverse patient communities.
Researchers have made progress toward a new form of light-activated gene therapy for cartilage repair, which is safe and compatible with existing surgical techniques. The therapy uses UV light to target specific cells and promote tissue growth, offering hope for treating knee injuries and potentially other conditions.
Researchers identified an intrinsic pathway involving PTEN that regulates stem cell transitions between quiescence and activity. Disrupting PTEN leads to increased active cycling and loss of quiescent stem cells, hindering long-term maintenance.
Researchers have found cancer cells suppress entire chromosome bands through epigenetic changes, silencing genes that prevent tumor growth. The discovery could lead to new treatments targeting DNA demethylation.
Researchers discover the structure of the WRN exonuclease domain, revealing its role in repairing DNA damage and maintaining genomic integrity. The study sheds light on the mechanisms underlying Werner's syndrome, a rare inherited disease that accelerates aging.
A study of over 39,000 women found that hormone therapy reduced the risk of heart attacks by 32% for those starting treatment in their 50s. However, the risk increased in older women within the first year of treatment before it decreased after two years.
A study of 25,719 women found that five-year cancer survivors reported functional limitations, such as heavy household work and mobility issues. The authors highlight the need for interventions to prevent and reverse functional decline among elderly long-term cancer survivors.
Scientists have successfully reversed cell division, a process essential to life, and may use this discovery to control cancer development and metastasis. The research holds promise for preventing and treating birth defects and other conditions.
Researchers found that combining a PI3K inhibitor with Herceptin can reverse lack of response in HER2-positive breast cancer patients. The addition of a PI3K inhibitor showed significant benefit in halting tumor growth, especially in tumors lacking PTEN protein.
Researchers found that omega-3 fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) inhibited the growth of liver cancer cells, whereas omega-6 fatty acid arachidonic acid (AA) had no effect. The compounds induced apoptosis and decreased beta-catenin levels, which are involved in tumor progression.
Dasatinib has shown promise in treating leukemia patients resistant to standard therapies, with 93% complete hematologic response and 45% major cytogenetic response. However, relapses have occurred in certain patient groups due to dasatinib-resistant BCR-ABL mutations.
Researchers report three cases of advanced cancers with long survival times after high-dose intravenous vitamin C therapy. The study suggests that high-dose intravenous vitamin C should be reassessed as a potential cancer treatment option.
Research reveals that men's concerns about controlling their cancer drive treatment choices, despite limited reliance on scientific evidence. The study highlights the need for improved patient education and informed decision-making support.
A study by U-M researchers found that patients with delayed surgery (more than 93 days) had worse survival rates and lower three-year survival rates compared to those with timely surgery. Scheduling issues were the most common cause of delay, which can lead to micrometastases and poor outcomes.
A new study found that weight training significantly improved the quality of life for breast cancer survivors, reducing symptoms such as depression and anxiety. The exercise program also increased lean body mass and upper body strength.
The European School of Oncology task force recommends a multidisciplinary approach to managing metastatic breast cancer, prioritizing patient psychological wellbeing and disease-specific treatment goals. Patients with MBC should be offered psychosocial support and involved in decision-making.
A breakthrough project in the Netherlands dramatically improved patient care for breast cancer patients by implementing structured best practices. The initiative reduced waiting times to under a week and increased pre-operative multidisciplinary consultations, leading to more clear-cut diagnoses and fewer unnecessary operations.
Tadatsugu Taniguchi is honored with the international award for his major scientific discovery in basic cancer research, elucidating cytokine gene families and transcription factors. He made significant contributions to our understanding of immune defense mechanisms and cancer therapy.
The UK Biobank project is a revolutionary research undertaking that will gather and store vast amounts of medical data from 40,000 to 69-year-old volunteers. Researchers hope to identify more reliable reasons for why some people develop specific diseases and others do not.
A study identifies molecular subclasses of high-grade gliomas that correlate with disease progression and prognosis. The subtypes resemble stages in neurogenesis, suggesting new insights for therapeutic intervention.
Researchers found that Aldara Cream reduced fine lines and wrinkles, improved skin texture, and enhanced color in prematurely aged skin. The cream showed significant improvements in 80% of the subjects, with 90% expressing strong approval.
The Australian government has pledged $50 million to support the expansion of the Walter and Eliza Hall Institute's (WEHI) research capabilities in cancer and infectious disease. This funding will enable significant expansions in the institute's research programs, focusing on targeted therapies for cancer treatment and malaria control.
A study found that internet use increases feelings of control among cancer patients, allowing them to view their relationship with doctors as a partnership. Online access also enables patients to make informed decisions about their treatment.
A study suggests that delayed surgical intervention can be a safe alternative to immediate treatment for men diagnosed with early-stage, low-grade prostate cancer. The research found equivalent risks of noncurable prostate cancer in both groups, depending on factors like age and PSA levels.
A study by the North Central Cancer Treatment Group found that reducing epoetin alfa dosing frequency from once weekly to every three weeks did not significantly impact hemoglobin levels or require transfusions. Patients in both treatment groups reported similar quality of life at the end of the 21-week study.
Researchers found a substantial link between severe rheumatoid arthritis and increased risk of lymphoma. Patients with high RA activity experienced a 70-fold increase in lymphoma risk, while those with low activity had an 8-fold increase.
Experts warn that sharing study results with participants could negatively impact their future health due to potential regret over less effective treatments. A revised informed consent strategy is proposed to balance individual rights with the need for transparency.
Researchers found that a common osteoporosis treatment helped men with prostate cancer recover significant bone mass after two years of androgen deprivation therapy. The study suggests that bone density tests should be encouraged for men at risk, and bone-preserving therapy could prevent debilitating fractures.
A recent study by Dr. Elizabeth Krall Kaye found that cigarette smokers are 70% more likely to need root canal treatment than nonsmokers. Quitting smoking is linked to a lower risk of needing the procedure.
A six-week program combining a nicotine patch and group support significantly increased the chances of women in public housing quitting smoking. The study found nearly 50% of women in the treatment group quit smoking by the end of the program, compared to less than 8% in the comparison group.
Kereos is developing a nanotechnology program to diagnose and treat cancer, detecting solid tumors as small as 1-2 mm. The technology can deliver high concentrations of chemotherapeutic agents to tumors with low standard doses.
A population-based case-control study found that women using medium potency estrogen-progestin combination therapy had a higher risk of developing lobular or tubular breast cancer. The risk was more pronounced for those who used the therapy for over five years, with a notable increase in the incidence of tubular and lobular cancers.
Researchers have identified the stage-specific roles of individual cathepsins in tumorigenesis, revealing that inhibiting cathepsin B, L, and S suppresses cancer development. The study found that these cathepsins promote tumor invasion by cleaving E-cadherin.
A study of 61,228 men aged 65 and older with local or regional stage prostate cancer found that lower socioeconomic status was significantly associated with decreased survival. Socioeconomic factors, including education level and community poverty, were the primary drivers of disparities in survival.
A blood test measuring NT-proBNP levels can accurately predict one-year mortality risk in patients with shortness of breath, regardless of underlying heart failure diagnosis. The study suggests that this test should be routinely used to identify high-risk patients needing more intensive treatment and follow-up.
Researchers found that excisional treatments, such as cold knife conisation and Large Loop Excision of the Transformation Zone (LLETZ), are associated with a small but real increase in risk of pregnancy-related morbidity. The findings suggest that cervical screening after the age of 25 may be beneficial for long-term obstetric outcomes.
Researchers at Florida State University have discovered a molecular mechanism that inhibits HCV replication in vitro after host cells become crowded. The study's new test can quickly monitor HCV replication and has the potential to lead to better, targeted treatments for this complex virus.
A recent study suggests that lung cancer survival rates may be tied to access to standard cancer care, rather than racial disparities. Researchers analyzed data from 995 patients with advanced small cell lung cancer and found that equal treatment yielded the same outcomes for black and non-black patients, regardless of stage or ethnicity.
Researchers have alleviated symptoms of Rett syndrome in mice by hyper-expressing the BDNF gene, which showed a drastic reduction in lethargy and improved cortical neuron activity. The findings may lead to potential therapeutic strategies for treating the condition.
The five-year data demonstrate long-term efficacy and reliability of MAL-PDT for treating superficial and nodular basal cell carcinomas, with superior cosmesis compared to cryotherapy. The treatment was found to be non-inferior to surgery in relation to initial response rates, but with significantly better cosmetic outcomes.
A common molecular signature of miRNA expression has been identified in solid tumors, providing insight into gene regulation and potential new approaches for diagnosis and treatment. This finding confirms the importance of microRNAs in growth and survival across species.
Researchers at the University of Nevada and Los Alamos National Laboratory have developed a breakthrough in concentrating carbon ion beams, a crucial step towards improving cancer tumor treatment. The innovation also opens up opportunities for advances in nuclear fusion applications.
The Tumor-Host Genomics project aims to understand the molecular and cellular interactions between tumor cells and their microenvironment. By developing advanced functional genomics instruments and technologies, researchers hope to identify new targets for anti-cancer therapy.
A new prediction rule identifies patients with pulmonary embolism who are at low risk of short-term mortality and other adverse medical outcomes, making them eligible for outpatient treatment. The model accurately predicted low-risk patients in two studies, resulting in very low mortality rates within 30 days.
A study of 200 patients with head and neck cancer found that those with lower quality of life one year after treatment were more likely to die. The researchers discovered a correlation between steady-state QOL and long-term survival, suggesting that adjusting to the diagnosis and treatment may be crucial for better outcomes.
A two-year study of patients with early, aggressive RA demonstrates the superiority of anti-TNF plus DMARD therapy over either treatment alone. Nearly half of participants in the combined therapy group achieved major clinical remission after 2 years.
A four-month study found that art therapy sessions improved eight out of nine symptoms in cancer patients, with significant reductions in pain, tiredness, and anxiety. Patients reported feeling energized and benefited from the creative process as a form of expression.
Researchers found that a modest decrease in Mdm2 protein expression prevents tumor formation and does not lead to premature aging. Inhibitors of Mdm2 may delay cancer in young individuals without detrimental side effects.
A study by Dana-Farber Cancer Institute found that black lung cancer patients are less likely to undergo surgery, despite equal access to care. The researchers attributed this disparity to a complex 'communications problem' underlying the interaction between doctors and patients.
Researchers at Children's Hospital of Philadelphia found that parents of children with cancer often suffer from post-traumatic stress symptoms, including intrusive thoughts, avoidance behaviors, and heightened arousal. The studies suggest that these symptoms can be just as severe as those experienced by patients themselves.
A new study reveals that palliative care programs are increasingly available in US hospitals, particularly in larger institutions and those affiliated with not-for-profit organizations. The growing demand for quality of life and relief from suffering is driving the expansion of these programs.
A study of lung cancer patients found that those who did not participate in clinical trials were more likely to be African American, female, or over 70. The researchers suggest targeting specific patient subgroups to improve representation in clinical trials.
The Mayo Clinic Cancer Center has reported significant advancements in quality of life assessments for cancer patients. The researchers tackled philosophical and statistical issues to develop practical methods for capturing QOL data. They emphasized the importance of including patient perspectives to provide personalized care.
A new initiative launched by UICC's World Cancer Campaign will provide funding for 14 projects aimed at improving childhood cancer care in the developing world. The initiatives focus on early diagnosis, access to care, and support for children with cancer and their families.
Patients who quit smoking around cancer diagnosis have improved disease outcomes, better QOL, and prolonged survival compared to continuing smokers. Targeted interventions combining behavioral therapy and pharmacotherapy show promise in addressing individual barriers to cessation.
A systematic review of randomized controlled trials and meta-analysis found that melatonin reduced the risk of death at one year by 34%. Melatonin was also shown to have a beneficial effect on sleep patterns in patients. The researchers urge caution in interpreting the clinical usefulness of large doses of melatonin.
Hospital noise levels have grown steadily over the past five decades, exceeding World Health Organization guidelines, with human speech frequency range contributing to communication difficulties. Researchers at Johns Hopkins University found modest reductions by introducing hands-free personal communicators in patient areas.
A study of 24 patients found that MRI with an endorectal coil at 1.5T outperforms conventional body coils in staging prostate cancer. The results suggest a need for advances in coil technology to improve imaging at higher field strengths.
Researchers at Ohio State University discover cancer wasting is caused by loss of muscle protein dystrophin and damage to the dystrophin glycoprotein complex. This finding may lead to new ways to diagnose and treat the condition.